We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

11 hedge funds and large institutions have $10.9M invested in Champions Oncology in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

39.4% more ownership

Funds ownership: 0% → 39.4% (+39%)

27% more capital invested

Capital invested by funds: $8.62M → $10.9M (+$2.32M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

35% less funds holding

Funds holding: 17 → 11 (-6)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
11
Holders Change
-6
Holders Change %
-35.29%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
2
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$63.1K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$53.7K

Top Sellers

Rank Fund Capital Flow
1
PCM
PAR Capital Management
Massachusetts
-$646K
2
SM
Sabby Management
Florida
-$555K
3
KCM
Knoll Capital Management
Florida
-$184K
4
Millennium Management
Millennium Management
New York
-$37K
5
VKH
Virtu KCG Holdings
New York
-$35.6K

CSBR Hedge Fund Activity: Q4 2016 in Review

11 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q4 2016, worth a combined $10.9M — up 27% from $8.62M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CSBR and 0 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Vanguard Group, adding an estimated $63.1K. The largest seller was PAR Capital Management, exiting entirely with an estimated $646K sold.

  • 11 institutional investors held Champions Oncology (CSBR) as of Q4 2016, down from 17 in Q3 2016.
  • Funds reported $10.9M of Champions Oncology stock for Q4 2016, up 27% quarter-over-quarter.
  • 0 funds opened new Champions Oncology positions in Q4 2016 and 6 closed out, a net change of -6 holders.
  • The largest Champions Oncology buyer in Q4 2016 was Vanguard Group, an estimated $63.1K added.
  • The largest Champions Oncology seller in Q4 2016 was PAR Capital Management, an estimated $646K sold.

Based on aggregated 13F filings for Q4 2016.